Back
The Goldman Sachs Group Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
78
GS
The Goldman Sachs Group
Last Price:
427.01
Seasonality Move:
1.49%
Sell
16
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-20.46%
Buy
78
The Goldman Sachs Group (GS)
is a Buy
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $427.57. The Score for GS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- GS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $427.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $23.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
GS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.02 | Buy |
| Relative Strength Index (14 RSI): | 65.45 | Buy |
| Chaikin Money Flow: | 1805806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (400.26 - 418.34) | Buy |
| Bollinger Bands (100): | (371.69 - 405.29) | Buy |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.44 | Sell |
| Relative Strength Index (14 RSI): | 34.11 | Sell |
| Chaikin Money Flow: | -30640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.57 - 31.31) | Sell |
| Bollinger Bands (100): | (18.43 - 29.93) | Sell |
GS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 415.38 | Buy |
| 20-day SMA: | 409.09 | Buy |
| 50-day SMA: | 399.64 | Buy |
| 200-day SMA: | 358.46 | Buy |
| 8-day EMA: | 417.24 | Buy |
| 20-day EMA: | 410.26 | Buy |
| 50-day EMA: | 400.66 | Buy |
| 200-day EMA: | 369.43 | Buy |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.7 | Sell |
| 20-day SMA: | 26.48 | Sell |
| 50-day SMA: | 28.52 | Sell |
| 200-day SMA: | 19.19 | Buy |
| 8-day EMA: | 24.68 | Sell |
| 20-day EMA: | 26.35 | Sell |
| 50-day EMA: | 26.76 | Sell |
| 200-day EMA: | 21.52 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.24 per share, an increase next quarter of $1.13 per share, an increase this year of $13.62 per share, and an increase next year of $3.47 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
The Goldman Sachs Group Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||